gamma Catenin peptide - phospho Y550 (ab42715)
Our Abpromise guarantee covers the use of ab42715 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
ELISA: Use at a concentration of 10-100 ng/well.
ICC/IF: Use at a concentration of 1 µg/ml.
WB: Use at a concentration of 1 µg/ml. Predicted molecular weight: 81 kDa.
This peptide blocks the activity of ab29041.
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
- ARVD 12ARVD12Catenin (cadherin associated protein), gamma 80kDa
- catenin (cadherin-associated protein) gamma (80kD)Catenin gammaCTNNGDesmoplakin 3Desmoplakin IIIDesmoplakin-3Desmoplakin3DesmoplakinIIIDP 3DP IIIDP3DPIIIgamma cateninJunction plakoglobinJUPOTTHUMP00000164732OTTHUMP00000164735OTTHUMP00000164738PDGBPKGBPLAK_HUMANPLAKOGLOBIN
Defects in JUP are the cause of familial arrhythmogenic right ventricular dysplasia type 12 (ARVD12) [MIM:611528]; also called arrhythmogenic right ventricular cardiomyopathy 12 (ARVC12). ARVD is an autosomal dominant disease characterized by partial degeneration of the myocardium of the right ventricle, electrical instability, and sudden death. It is clinically defined by electrocardiographic and angiographic criteria; pathologic findings, replacement of ventricular myocardium with fatty and fibrous elements, preferentially involve the right ventricular free wall.
Contains 9 ARM repeats.
References for gamma Catenin peptide - phospho Y550 (ab42715)
ab42715 has not yet been referenced specifically in any publications.